Financial statements Polfarmex Biotechnologie
Cash flow statement of Polfarmex Biotechnologie
Company age:
Age:
10 y. 9 m. 24 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of POLFARMEX BIOTECHNOLOGIE
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Net cash from operating expenses | -13 121,03 | -15 378,55 | -14 743,52 | -4 381,36 |
| Net cash flow from investing activities | 0,00 | 0,00 | 0,00 | 0,00 |
| Net cash flow from financial activities | 50 000,00 | 0,00 | 0,00 | 0,00 |
| Total net cash flow | 36 878,97 | -15 378,55 | -14 743,52 | -4 381,36 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.